The Analysis of Factors Influencing Immunologic Reactivity in People Vaccinated with a Live Plague Vaccine

Introduction: An increase in epizootic activity has been registered in a number of plague foci in the Russian Federation over the past few years. As part of securing sanitary and epidemiologic wellbeing of the population living in the natural foci of the disease, a mass immunization with a live plague vaccine based of the Yersinia pestis EV line NIIEG vaccine strain was carried out. Objectives: The purpose of the study was to assess the influence of a complex of factors including age, gender, health status, the number of previous vaccinations against plague, blood groups, and HLA gene polymorphism on the state of the cellular and humoral immune response in people vaccinated with the live plague vaccine. Materials and methods: The analysis of venous blood of 347 volunteers included determination of the concentration of specific antibodies to the capsular antigen (F1) of plague microbe, spontaneous and induced production of marker cytokines (IFN-γ, TNF-α, and IL-4) by ELISA, and genes of the main histocompatibility complex (HLA) class II by real-time PCR. We also analyzed medical documentation (Form 025/u) and the results of a questionnaire-based survey of the vaccinated people. Results and discussion: We established the influence of various factors, including genetic ones, on marker indicators of the humoral and cellular immune response in persons vaccinated with the live plague vaccine. We also characterized the relationship between the level of specific antibodies to plague microbe F1 production and some cytokines and the age and the number of previous vaccinations in our volunteers. The most common gene variants of the main histocompatibility complex of class II (HLA-DQA1, HLA-DQB1 and HLA-DRB1) in the cohort were identified and possible relationships between the production of IFN-γ, TNF-α, IL-4 and allelic polymorphism of HLA class II genes were determined. Conclusions: Immunologic reactivity in people vaccinated with the live plague vaccine is mainly determined by age, the number of previous vaccinations against this infection, and individual characteristics of HLA gene polymorphism.

иммунологический мониторинг, специфическая профилактика чумы, цитокины, полиморфизм генов HLA, immunologic monitoring, specific plague prevention, cytokines, HLA gene polymorphism

1. Попов Н.В., Карнаухов И.Г., Пакскина Н.Д. и др. Оценка современной эпидемиологической обстановки в природных очагах чумы мира. Повышение эффективности эпидемиологического надзора в природных очагах чумы Российской Федерации и прогноз их эпизоотической активности на 2019 г. // Проблемы особо опасных инфекций. 2019. № 1. С. 81-88.

2. Брико Н.И., Лобзин Ю.В., Баранов А.А. и др. Оценка эффективности вакцинации: основные подходы и спорные вопросы // Педиатрическая фармакология. 2014. Т. 11. № 4. С. 8-15.

3. Philipovskiy AV, Smiley ST. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun. 2007; 75(2):878-85. DOI: https://doi.org/10.1128/IAI.01529-06

4. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015; 28(3):801-70. DOI: https://doi.org/10.1128/CMR.00109-14

5. Heggelund JE, Varrot A, Imberty A, et al. Histoblood group antigens as mediators of infections. Curr Opin Struct Biol. 2017; 44:190-200. DOI: https://doi. org/10.1016/j.sbi.2017.04.001

6. Медуницын Н.В., Миронов А.Н. Вакцины. Новые способы повышения эффективности и безопасности вакцинации // Вопросы вирусологии. 2012. № S1. С. 43-51.

7. Poland GA, Ovsyannikova IG, Kennedy RB, et al. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS. 2011; 15(9):625-36. DOI: https://doi.org/10.1089/ omi.20n.0032

8. Neefjes J, Jongsma ML, Paul P, et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011; 11(12):823-36. DOI: https://doi.org/10.1038/nri3084

9. Бугоркова С.А., Щуковская Т.Н., Микшис Н.И. и др. Комплексное иммунологическое исследование вакцинированных живой чумной вакциной лиц, проживающих на территории Прикаспийского песчанного очага чумы в Республике Калмыкия // Эпидемиология и вакцинопрофилактика. 2018. Т. 17, № 3 (100). С. 38-49

10. Бугоркова С.А., Щуковская Т.Н., Микшис Н.И. и др. Научно-методическое обеспечение мероприятий по проведению иммунологического мониторинга вакцинированных против чумы лиц, проживающих на территориях природных очагов инфекции // Проблемы особо опасных инфекций. 2018. № 2. С. 6-13.

11. Sagiyev Z, Berdibekov A, Bolger T, et al. Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015. PLoS ONE. 2019; 14(6):e0218366.

12. Wiegering V, Eyrich M, Wunder C, et al. Age-related changes in intracellular cytokine expression in healthy children. Eur Cytokine Netw. 2009; 20(2):75-80. DOI: https://doi.org/10.1684/ecn.2009.0149

13. Fisman DN, Agrawal D, Leder K. Effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis. Clin Infect Dis. 2002; 35(11):1368-75. DOI: https://doi.org/10.1086/344271

14. Ovsyannikova IG, Pankratz VS, Vierkant RA, et al. Consistency of HLA associations between two independent measles vaccine cohorts: A replication study. Vaccine. 2012; 30(12):2146-52. DOI: https:// doi.org/10.1016/j.vaccine.2012.01.038

15. Ovsyannikova IG, Pankratz VS, Vierkant RA, et al. Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed. Infect Immun. 2013; 81(7):2584-91. DOI: https://doi.org/10.n28/ IAI.00269-13

16. Дятлов И.И., Фирстова В.В., Бондаренко Н.Л. и др. Стратегия оценки поствакцинального иммунитета против туляремии и чумы // Аллергология и иммунология. 2016. Т. 17. № 2. С. 112-114.

17. Корытов К.М., Войткова В.В., Дубровина В.И. и др. Оценка иммунологической эффективности вакцинации населения против чумы в Горно-Алтайском высокогорном природном очаге // Эпидемиология и вакцинопрофилактика. 2018. Т. 17. № 6. С. 87-97.

18. Кудрявцева О.М., Бугоркова С.А., Щуковская Т.Н. и др. Ассоциация показателей функциональной активности маркеров Th1 и Th2 иммунитета с полиморфизмом генов HLA у лиц, вакцинированных против чумы // Инфекция и иммунитет. 2019. Т. 9, № 2. С. 315-324.

19. Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today. 1993; 14(7):349-52. DOI: https://doi. org/10.1016/0167-5699(93)90234-C